These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 3318401)

  • 1. Role of antacids in the management of disorders of the upper gastrointestinal tract. Review of clinical experience 1975-1985.
    Lanza FL; Sibley CM
    Am J Gastroenterol; 1987 Dec; 82(12):1223-41. PubMed ID: 3318401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antacids: clinical pharmacology and therapeutic uses.
    Anand BS
    Trop Gastroenterol; 1985; 6(2):63-8. PubMed ID: 3937305
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug therapy: Cimetidine.
    Finkelstein W; Isselbacher KJ
    N Engl J Med; 1978 Nov; 299(18):992-6. PubMed ID: 357977
    [No Abstract]   [Full Text] [Related]  

  • 4. Review article: acid-related disease--what are the unmet clinical needs?
    Katz PO; Scheiman JM; Barkun AN
    Aliment Pharmacol Ther; 2006 Jun; 23 Suppl 2():9-22. PubMed ID: 16700899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antacids.
    Hendrix TR
    Am Fam Physician; 1974 Mar; 9(3):184-6. PubMed ID: 4813464
    [No Abstract]   [Full Text] [Related]  

  • 6. [Complicated ulcer; prevention and therapy of upper gastrointestinal bleeding; indications for antacid therapy].
    Holtermüller KH
    Z Gastroenterol; 1980 Jun; 18(6):297-301. PubMed ID: 7415351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antacid therapy for duodenal and gastric ulcer: the experience in the United States.
    Ippoliti AF
    Scand J Gastroenterol Suppl; 1982; 75():82-5. PubMed ID: 6755655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use and abuse of histamine H2-receptor antagonists.
    Milton-Thompson GJ
    J R Nav Med Serv; 1977; 63(1):9-14. PubMed ID: 17005
    [No Abstract]   [Full Text] [Related]  

  • 9. Pathogenesis, diagnosis and treatment of acute gastric mucosal lesions.
    Marrone GC; Silen W
    Clin Gastroenterol; 1984 May; 13(2):635-50. PubMed ID: 6430609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Present and future treatment of peptic ulcer and potential role of DE-NOL.
    Scand J Gastroenterol Suppl; 1982; 80():49-57. PubMed ID: 6761852
    [No Abstract]   [Full Text] [Related]  

  • 11. Controlled clinical assessment of the efficacy and tolerance of triletide versus antacids in patients with gastric and duodenal ulcers.
    Hoetzinger H
    Pharmatherapeutica; 1985; 4(3 Spec No):155-60. PubMed ID: 3903784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antacid effect of a magnesium trisilicate-1-hyoscyamine combination preparation (Neoplex B)--clinical and function analytical studies].
    Piaty R
    Wien Med Wochenschr; 1968 Feb; 118(8):157-9. PubMed ID: 4301560
    [No Abstract]   [Full Text] [Related]  

  • 13. Optimizing the pharmacology of acid control in acid-related disorders.
    Howden CW
    Am J Gastroenterol; 1997 Apr; 92(4 Suppl):17S-19S; discussion 19S-21S. PubMed ID: 9127622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Review and study of the immediate results of medical treatment of 283 patients with various esophageal-gastrointestinal processes].
    Martínez Obrador D; Balanza Ortíz E
    Rev Esp Enferm Apar Dig; 1972 Mar; 36(6):735-52. PubMed ID: 5017112
    [No Abstract]   [Full Text] [Related]  

  • 15. Review article: the unmet needs in delayed-release proton-pump inhibitor therapy in 2005.
    Hunt RH
    Aliment Pharmacol Ther; 2005 Dec; 22 Suppl 3():10-9. PubMed ID: 16303032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of acid-related disorders in the United States.
    Brown M; Yang RD
    Manag Care; 2001 Oct; 10(10 Suppl):7-10. PubMed ID: 11729446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical treating of antacids].
    Lux G; Lux E
    Fortschr Med; 1973 May; 91(14):638-40. PubMed ID: 4540765
    [No Abstract]   [Full Text] [Related]  

  • 18. [Experience in the use of losek (omeprazole) in gastroenterology].
    Maev IV; V'iuchnova ES; Lebedev EG; Dicheva DT; Ovsiannikova EV; Antonenko OM; Shchekina MI
    Ter Arkh; 2001; 73(7):79-82. PubMed ID: 11523419
    [No Abstract]   [Full Text] [Related]  

  • 19. [H2 blockers and antacids in gastrointestinal diseases].
    Stein J; Rösch W
    Pharm Unserer Zeit; 2007; 36(1):38-43. PubMed ID: 17283749
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prevention and therapy of acute gastrointestinal hemorrhage].
    Rösch W
    Leber Magen Darm; 1985 Sep; 15(5):198-204. PubMed ID: 3877231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.